SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.0001000+899.9%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas C. White who wrote (659)9/17/1997 3:54:00 PM
From: WeirdPro Randy   of 1359
 
I agree with Thomas White on liabilitiy issues and see today's carnage as panic.....not to say panic won't continue a bit longer. But AHP will be the primary target by far.
Liablity will also fall on the physician's who prescribed the drugs ( esp. the highly publicized weight clinic), and it is fenturamine, not dexfenturamine, which is the implicated agent in the majority of cases/data so far.....certainly IPIC has no liability here.
The value of Redux to the company was very small compared to values in its pipeline.......and the threat of monies to fight/pay for lawsuits will come out of IPIC's insurance company, not from future IPIC revenues.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext